Literature DB >> 23904402

Fine-needle aspiration cytology of T-lymphoblastic lymphoma associated FGFR1 rearrangement myeloproliferative neoplasm.

Rishi A Patel1, Andrea M Sheehan, Christie J Finch, Dolores Lopez-Terrada, Vivian S Hernandez, Choladda V Curry.   

Abstract

FNA of T-lymphoblastic lymphoma associated FGFR1 rearranged MPN.
Copyright © 2013 Wiley Periodicals, Inc.

Entities:  

Keywords:  8p11 myeloproliferative neoplasm (MPN); 8p11 myeloproliferative syndrome; Fibroblast growth factor receptor 1 (FGFR1); T-lymphoblastic lymphoma (T-LBL); fine needle aspiration (FNA); t(8;13)(p11;q12)

Mesh：

Substances：

Year:  2013        PMID： 23904402      PMCID： PMC4100463          DOI： 10.1002/dc.23030

Source DB:  PubMed          Journal:  Diagn Cytopathol        ISSN： 1097-0339            Impact factor:   1.582


  5 in total

1.  T-cell lymphoblastic lymphoma with eosinophilia associated with subsequent myeloid malignancy.

Authors:  L V Abruzzo; E S Jaffe; J D Cotelingam; J Whang-Peng; V Del Duca; L J Medeiros
Journal:  Am J Surg Pathol       Date:  1992-03       Impact factor: 6.394

Review 2.  The 8p11 myeloproliferative syndrome: a distinct clinical entity caused by constitutive activation of FGFR1.

Authors:  D Macdonald; A Reiter; N C P Cross
Journal:  Acta Haematol       Date:  2002       Impact factor: 2.195

Review 3.  8p11 myeloproliferative syndrome: a review.

Authors:  Courtney C Jackson; L Jeffrey Medeiros; Roberto N Miranda
Journal:  Hum Pathol       Date:  2010-04       Impact factor: 3.466

Review 4.  A syndrome of lymphoblastic lymphoma, eosinophilia, and myeloid hyperplasia/malignancy associated with t(8;13)(p11;q11): description of a distinctive clinicopathologic entity.

Authors:  R C Inhorn; J C Aster; S A Roach; C A Slapak; R Soiffer; R Tantravahi; R M Stone
Journal:  Blood       Date:  1995-04-01       Impact factor: 22.113

Review 5.  A new myeloproliferative disorder associated with chromosomal translocations involving 8p11: a review.

Authors:  D Macdonald; R C Aguiar; P J Mason; J M Goldman; N C Cross
Journal:  Leukemia       Date:  1995-10       Impact factor: 11.528
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.